↓ Skip to main content

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, June 2009
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
162 Dimensions

Readers on

mendeley
95 Mendeley
Title
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
Published in
Cancer Chemotherapy and Pharmacology, June 2009
DOI 10.1007/s00280-009-1041-6
Pubmed ID
Authors

Brian Thiessen, Clinton Stewart, Ming Tsao, Suzanne Kamel-Reid, Paula Schaiquevich, Warren Mason, Jacob Easaw, Karl Belanger, Peter Forsyth, Lynn McIntosh, Elizabeth Eisenhauer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Korea, Republic of 1 1%
Brazil 1 1%
Unknown 92 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 20%
Student > Ph. D. Student 17 18%
Student > Master 11 12%
Student > Doctoral Student 7 7%
Student > Bachelor 4 4%
Other 12 13%
Unknown 25 26%
Readers by discipline Count As %
Medicine and Dentistry 22 23%
Biochemistry, Genetics and Molecular Biology 12 13%
Agricultural and Biological Sciences 12 13%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Neuroscience 5 5%
Other 8 8%
Unknown 31 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2015.
All research outputs
#7,856,604
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#688
of 2,501 outputs
Outputs of similar age
#39,825
of 116,306 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#4
of 14 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 116,306 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.